These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 24389582)
1. The structural basis for the negative regulation of thioredoxin by thioredoxin-interacting protein. Hwang J; Suh HW; Jeon YH; Hwang E; Nguyen LT; Yeom J; Lee SG; Lee C; Kim KJ; Kang BS; Jeong JO; Oh TK; Choi I; Lee JO; Kim MH Nat Commun; 2014; 5():2958. PubMed ID: 24389582 [TBL] [Abstract][Full Text] [Related]
2. The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange. Patwari P; Higgins LJ; Chutkow WA; Yoshioka J; Lee RT J Biol Chem; 2006 Aug; 281(31):21884-21891. PubMed ID: 16766796 [TBL] [Abstract][Full Text] [Related]
3. Mutagenic analysis in a pure molecular system shows that thioredoxin-interacting protein residue Cys247 is necessary and sufficient for a mixed disulfide formation with thioredoxin. Fould B; Lamamy V; Guenin SP; Ouvry C; Cogé F; Boutin JA; Ferry G Protein Sci; 2012 Sep; 21(9):1323-33. PubMed ID: 22760822 [TBL] [Abstract][Full Text] [Related]
4. Thioredoxin interacting protein: redox dependent and independent regulatory mechanisms. Spindel ON; World C; Berk BC Antioxid Redox Signal; 2012 Mar; 16(6):587-96. PubMed ID: 21929372 [TBL] [Abstract][Full Text] [Related]
8. Dl-3-n-Butylphthalide Inhibits NLRP3 Inflammasome and Mitigates Alzheimer's-Like Pathology via Nrf2-TXNIP-TrX Axis. Wang CY; Xu Y; Wang X; Guo C; Wang T; Wang ZY Antioxid Redox Signal; 2019 Apr; 30(11):1411-1431. PubMed ID: 29634349 [TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid Upregulates Thioredoxin-interacting Protein in Cultured Neuronal Cells. Bharti V; Tan H; Chow D; Wang Y; Nagakannan P; Eftekharpour E; Wang JF Neuroscience; 2018 Aug; 384():375-383. PubMed ID: 29894818 [TBL] [Abstract][Full Text] [Related]
10. Thioredoxin-interacting protein mediates TRX1 translocation to the plasma membrane in response to tumor necrosis factor-α: a key mechanism for vascular endothelial growth factor receptor-2 transactivation by reactive oxygen species. World C; Spindel ON; Berk BC Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1890-7. PubMed ID: 21636804 [TBL] [Abstract][Full Text] [Related]
11. Structure of the N-terminal domain of human thioredoxin-interacting protein. Polekhina G; Ascher DB; Kok SF; Beckham S; Wilce M; Waltham M Acta Crystallogr D Biol Crystallogr; 2013 Mar; 69(Pt 3):333-44. PubMed ID: 23519408 [TBL] [Abstract][Full Text] [Related]
12. Hyperglycemia regulates TXNIP/TRX/ROS axis via p38 MAPK and ERK pathways in pancreatic cancer. Li W; Wu Z; Ma Q; Liu J; Xu Q; Han L; Duan W; Lv Y; Wang F; Reindl KM; Wu E Curr Cancer Drug Targets; 2014; 14(4):348-56. PubMed ID: 24720336 [TBL] [Abstract][Full Text] [Related]
14. TXNIP: A Double-Edged Sword in Disease and Therapeutic Outlook. Pan M; Zhang F; Qu K; Liu C; Zhang J Oxid Med Cell Longev; 2022; 2022():7805115. PubMed ID: 35450411 [TBL] [Abstract][Full Text] [Related]
16. Thioredoxin-1 is a novel and attractive therapeutic approach for various diseases including cardiovascular disorders. Billiet L; Rouis M Cardiovasc Hematol Disord Drug Targets; 2008 Dec; 8(4):293-6. PubMed ID: 19075641 [TBL] [Abstract][Full Text] [Related]